Celularity (CELU) Net Margin (QoQ) (2020 - 2025)
Powered by 
Analysis
Celularity (CELU) Net Margin (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -15,757.00 |
| Sep 30, 2025 | -906.00 |
| Jun 30, 2025 | -25,419.00 |
| Mar 31, 2025 | 175,843.00 |
| Dec 31, 2024 | -175,864.00 |
| Sep 30, 2024 | -11,962.00 |
| Jun 30, 2024 | 9,637.00 |
| Mar 31, 2024 | -22,876.00 |
| Dec 31, 2023 | 255,838.00 |
| Sep 30, 2023 | -84,753.00 |
| Jun 30, 2023 | -517.00 |
| Mar 31, 2023 | -221,863.00 |
| Dec 31, 2022 | 47,571.00 |
| Sep 30, 2022 | -115,052.00 |
| Jun 30, 2022 | 232,584.00 |
| Mar 31, 2022 | -97,606.00 |
| Dec 31, 2021 | -55,333.00 |
| Sep 30, 2021 | 248,830.00 |
| Jun 30, 2021 | 104,557.00 |
| Mar 31, 2021 | -318,430.00 |